Advertisement

 

 

Clinical implications of the plasma EphA2 receptor level in critically ill patients with septic shock.

Clinical implications of the plasma EphA2 receptor level in critically ill patients with septic shock.
Author Information (click to view)

Lee SH, Shin JH, Song JH, Leem AY, Park MS, Kim YS, Chang J, Chung KS,


Lee SH, Shin JH, Song JH, Leem AY, Park MS, Kim YS, Chang J, Chung KS, (click to view)

Lee SH, Shin JH, Song JH, Leem AY, Park MS, Kim YS, Chang J, Chung KS,

Advertisement

Scientific reports 2017 12 147(1) 17612 doi 10.1038/s41598-017-17909-7
Abstract

The Eph/ephrin receptor ligand system is known to play a role in inflammation induced by infection, injury, and inflammatory diseases. The present study aimed to evaluate plasma EphA2 receptor levels in critically ill patients with sepsis. This study was a prospective cohort study evaluating samples and clinical data from the medical intensive care unit (MICU) of a 2000-bed university tertiary referral hospital in South Korea. Positive correlations of the plasma EphA2 receptor level with the acute physiology and chronic health evaluation (APACHE) II score and the sequential organ failure assessment (SOFA) score were observed. The area under the curve (AUC) for the plasma EphA2 receptor level on a receiver operating characteristic curve was 0.690 (95% confidence interval [CI], 0.608-0.764); the AUCs for the APACHE II score and SOFA scores were 0.659 (95% CI, 0.576-0.736) and 0.745 (95% CI, 0.666-0.814), respectively. A Cox proportional hazard model identified an association between an increased plasma EphA2 receptor level (>51.5 pg mL-1) and increased risk of 28-day mortality in the MICU (hazard ratio = 3.22, 95% CI, 1.709-6.049). An increased plasma EphA2 receptor level was associated with sepsis severity and 28-day mortality among sepsis patients.

Submit a Comment

Your email address will not be published. Required fields are marked *

13 − eleven =

[ HIDE/SHOW ]